10,880
Views
64
CrossRef citations to date
0
Altmetric
ORIGINAL ARTICLES: SURVIVORSHIP

Long-term neuropathy and quality of life in colorectal cancer patients treated with oxaliplatin containing adjuvant chemotherapy

, , , , &
Pages 398-406 | Received 19 Nov 2018, Accepted 03 Dec 2018, Published online: 14 Jan 2019

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Bengt Glimelius & Peter Nygren. (2019) Lessons learned from the maturation of a cancer drug: oxaliplatin in colorectal cancer. Acta Oncologica 58:4, pages 395-397.
Read now

Articles from other publishers (63)

M. Zenatri, T. Perennec, C. Michon, F. Gernier, J.-M. Grellard, F.-X. Piloquet, C. Dubot-Poitelon, E. Kalbacher, O. Tredan, P. Augereau, P. Pautier, L. Fey, F. Joly & J.-S. Frenel. (2024) Pharmacogenomic predictor of long-term residual chemotherapy-induced peripheral neuropathy in ovarian cancer survivors: A substudy of the GINECO Vivrovaire study. Gynecologic Oncology 187, pages 139-144.
Crossref
Zishan Xu, Wei Li, Xiangyang Dong, Yingying Chen, Dan Zhang, Jingnan Wang, Lin Zhou & Guoyang He. (2024) Precision medicine in colorectal cancer: Leveraging multi-omics, spatial omics, and artificial intelligence. Clinica Chimica Acta 559, pages 119686.
Crossref
Lujia Chen, Ying Wang, Chunhui Cai, Ying Ding, Rim S. Kim, Corey Lipchik, Patrick G. Gavin, Greg Yothers, Carmen J. Allegra, Nicholas J. Petrelli, Jennifer Marie Suga, Judith O. Hopkins, Naoyuki G. Saito, Terry Evans, Srinivas Jujjavarapu, Norman Wolmark, Peter C. Lucas, Soonmyung Paik, Min Sun, Katherine L. Pogue-Geile & Xinghua Lu. (2024) Machine Learning Predicts Oxaliplatin Benefit in Early Colon Cancer. Journal of Clinical Oncology 42:13, pages 1520-1530.
Crossref
Jierong Han, Hengzhou Lai, Wenyuan Li, Huarui Liao, Chong Xiao, Xueke Li, Fengming You & Jing Guo. (2024) Efficacy and safety of traditional plant-based medicines for preventing chronic oxaliplatin-induced peripheral neurotoxicity in patients with colorectal cancer: A systematic review and meta-analysis with core herb contribution. Journal of Ethnopharmacology 326, pages 117735.
Crossref
Calixtus Abiodun Okere, Natalia Sak‐Dankosky, Victor Yerris & Tarja Kvist. (2024) Spiritual interventions: Improving the lives of colorectal cancer survivors—A systematic literature review. Journal of Advanced Nursing.
Crossref
Yu-Chen Su, Yeur-Hur Lai, Sung-Tsang Hsieh, Chieh-Lin Jerry Teng & Yun-Hsiang Lee. (2024) Acute, long-term or non-vincristine-induced peripheral neuropathy among non-Hodgkin lymphoma survivors: Symptoms, daily activities, functional status, and quality of life. European Journal of Oncology Nursing 69, pages 102540.
Crossref
Housem Kacem, Annamaria Cimini, Michele d’Angelo & Vanessa Castelli. (2024) Molecular and Cellular Involvement in CIPN. Biomedicines 12:4, pages 751.
Crossref
Arjun Prasad Tiwari, Bayne Albin, Khayzaran Qubbaj, Prashant Adhikari & In Hong Yang. (2024) Phytic Acid Maintains Peripheral Neuron Integrity and Enhances Survivability against Platinum-Induced Degeneration via Reducing Reactive Oxygen Species and Enhancing Mitochondrial Membrane Potential. ACS Chemical Neuroscience 15:6, pages 1157-1168.
Crossref
Jingjing Duan, Lila Zhu, Yinghui Shi, Weixue Wang, Tongtong Wang, Tao Ning, Le Zhang, Ming Bai, Hongli Li, Rui Liu, Shaohua Ge, Xia Wang, Yuchong Yang, Zhi Ji, Feixue Wang, Yansha Sun, Yi Ba & Ting Deng. (2024) Chemotherapy re-use versus anti-angiogenic monotherapy as the third-line treatment of patients with metastatic colorectal cancer: a real-world cohort study. BMC Cancer 24:1.
Crossref
E. S. Koneva, A. S. Mochalova, M. V. Alieskerov, A. E. Kashanova, V. A. Ogorodnikov, M. S. Suetina & E. N. Zhumanova. (2024) Assessing the impact of complex rehabilitation on peripheral polyneuropathy incidence and quality of life in patients with colorectal cancer. Fizioterapevt (Physiotherapist):1, pages 71-77.
Crossref
Yasir G. Malik, Jūratė Šaltytė Benth, Hanne M. Hamre, Arne E. Færden, Dejan Ignjatovic & Johannes K. Schultz. (2023) Chemotherapy reduces long‐term quality of life in recurrence‐free colon cancer survivors ( LaTE study)—a nationwide inverse probability of treatment‐weighted registry‐based cohort study and survey . Colorectal Disease 26:1, pages 22-33.
Crossref
A. Lemanska, A. Harkin, T. Iveson, C. Kelly, M. Saunders & S. Faithfull. (2023) The association of clinical and patient factors with chemotherapy-induced peripheral neuropathy (CIPN) in colorectal cancer: secondary analysis of the SCOT trial. ESMO Open 8:6, pages 102063.
Crossref
Allison B. Wang, Stephen N. Housley, Daniel Ludvig, Colin K. Franz, Ann Marie Flores, Timothy C. Cope & Eric J. Perreault. (2023) Cancer survivors post-chemotherapy exhibit unimpaired short-latency stretch reflexes in the proximal upper extremity. Journal of Neurophysiology 130:4, pages 895-909.
Crossref
Robert T. van Kooten, Bianca A. M. Schutte, Dorine J. van Staalduinen, Jetty H. L. Hoeksema, Fabian A. Holman, Chantal van Dorp, Koen C. M. J. Peeters, Rob A. E. M. Tollenaar & Michel W. J. M. Wouters. (2023) Patient perspectives on consequences of resection for colorectal cancer: A qualitative study. Colorectal Disease 25:8, pages 1578-1587.
Crossref
Chia‐Fen Hsieh, Ya‐Ning Chan, Chih‐Jung Wu, Li‐Yu Yen, Yu‐Chi Chang & Ya‐Jung Wang. (2023) Patient‐reported motor chemotherapy‐induced peripheral neuropathy impacts function in advanced colorectal cancer survivors receiving chemotherapy: A cross‐sectional study. Japan Journal of Nursing Science 20:3.
Crossref
Larissa Staurengo-Ferrari, Dionéia Araldi, Paul G. Green & Jon D. Levine. (2023) Neuroendocrine mechanisms in oxaliplatin-induced hyperalgesic priming. Pain 164:6, pages 1375-1387.
Crossref
A. Coolbrandt, H. Tobback, R. Govaerts, L. Vandezande, M. Vinckx, A. Laenen, H. Wildiers, C. Verslype, J. Dekervel, F. Van Herpe & E. Van Cutsem. (2023) A randomized controlled trial of hand/foot-cooling by hilotherapy to prevent oxaliplatin-related peripheral neuropathy in patients with malignancies of the digestive system. ESMO Open 8:2, pages 101205.
Crossref
Imen Toukabri Ben Mahmoud, Azza Ben Said, Souad Berguiga, Racha Houij, Ines Cherif, Adel Hamdi, Wiem Ben Ayed & Imen Limayem. (2021) Incidence and risk factors associated with development of oxalipatin-induced acute peripheral neuropathy in colorectal cancer patients. Journal of Oncology Pharmacy Practice 29:2, pages 311-318.
Crossref
Seohyuk Lee, Chao Ma, Qian Shi, Pankaj Kumar, Felix Couture, Philip Kuebler, Smitha Krishnamurthi, DeQuincy Lewis, Benjamin Tan, Richard M. Goldberg, Alan Venook, Charles Blanke, Eileen M. O'Reilly, Anthony F. Shields & Jeffrey A. Meyerhardt. (2023) Potential Mediators of Oxaliplatin-Induced Peripheral Neuropathy From Adjuvant Therapy in Stage III Colon Cancer: Findings From CALGB (Alliance)/SWOG 80702. Journal of Clinical Oncology 41:5, pages 1079-1091.
Crossref
Brianna & Sau Har Lee. (2023) Chemotherapy: how to reduce its adverse effects while maintaining the potency?. Medical Oncology 40:3.
Crossref
Allison B. Wang, Stephen N. Housley, Ann Marie Flores, Timothy C. Cope & Eric J. Perreault. (2022) Cancer survivors post-chemotherapy exhibit unique proprioceptive deficits in proximal limbs. Journal of NeuroEngineering and Rehabilitation 19:1.
Crossref
Timothée Olivier & Vinay Prasad. (2022) Molecular testing to deliver personalized chemotherapy recommendations: risking over and undertreatment. BMC Medicine 20:1.
Crossref
Stefanie Siebert, Jane Kersten, Sebastian Theurich & Freerk T. Baumann. (2022) Körperliche Aktivität bei Krebs – Wirksamkeit bewegungstherapeutischer Ansätze. TumorDiagnostik & Therapie 43:07, pages 473-480.
Crossref
Norah M. Alhoshani, Norah S. Al-Johani, Nora Alkeraishan, Saud Alarifi & Saad Alkahtani. (2022) Effect of lycopene as an adjuvant therapy with 5-florouracil in human colon cancer. Saudi Journal of Biological Sciences 29:9, pages 103392.
Crossref
Stefanie Siebert, Jane Kersten, Sebastian Theurich & Freerk T. Baumann. (2022) Körperliche Aktivität bei Krebs – Wirksamkeit bewegungstherapeutischer Ansätze. DMW - Deutsche Medizinische Wochenschrift 147:13, pages 831-840.
Crossref
Debbie Smit, Floortje Mols, Cynthia S. Bonhof, Martijn J. L. Bours, Gerard Vreugdenhil & Sandra Beijer. (2022) Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?. Supportive Care in Cancer 30:7, pages 6071-6078.
Crossref
Iulian Prutianu, Teodora Alexa-Stratulat, Elena Octaviana Cristea, Andrei Nicolau, Diana Cornelia Moisuc, Alina Alexandra Covrig, Karina Ivanov, Adina Emilia Croitoru, Monica Ionela Miron, Mihaela Ioana Dinu, Anca Viorica Ivanov, Mihai Vasile Marinca, Iulian Radu & Bogdan Gafton. (2022) Oxaliplatin-induced neuropathy and colo-rectal cancer patient’s quality of life: Practical lessons from a prospective cross-sectional, real-world study. World Journal of Clinical Cases 10:10, pages 3101-3112.
Crossref
Kristian K. Jensen, Jan H. Storkholm, Inna Chen, Stefan K. Burgdorf & Carsten P. Hansen. (2022) Long-term results after resection of primary duodenal adenocarcinoma: A retrospective cohort study. International Journal of Surgery 100, pages 106599.
Crossref
Eva M. Zopf, Holger Schulz, Jonas Poeschko, Kerstin Aschenbroich, Thomas Wilhelm, Ernst Eypasch, Elmar Kleimann, Kai Severin, Jutta Benz, Enwu Liu, Wilhelm Bloch & Freerk T. Baumann. (2021) Effects of supervised aerobic exercise on cardiorespiratory fitness and patient-reported health outcomes in colorectal cancer patients undergoing adjuvant chemotherapy—a pilot study. Supportive Care in Cancer 30:3, pages 1945-1955.
Crossref
Alessio Amatu, Gianluca Mauri, Federica Tosi, Katia Bencardino, Erica Bonazzina, Viviana Gori, Lorenzo Ruggieri, Sabrina Arena, Alberto Bardelli, Silvia Marsoni, Salvatore Siena & Andrea Sartore-Bianchi. (2022) Efficacy of Retreatment with Oxaliplatin-Based Regimens in Metastatic Colorectal Cancer Patients: The RETROX-CRC Retrospective Study. Cancers 14:5, pages 1197.
Crossref
Cindy Tofthagen, Mary Tanay, Adam Perlman, Jason Starr, Pooja Advani, Katharine Sheffield & Tara Brigham. (2022) A Systematic Review of Nutritional Lab Correlates with Chemotherapy Induced Peripheral Neuropathy. Journal of Clinical Medicine 11:2, pages 355.
Crossref
Ayoung Lee & Jin-Hee Park. (2022) Symptom Experience and Quality of Life in Colorectal Cancer Patients Undergoing Chemotherapy. Asian Oncology Nursing 22:3, pages 136.
Crossref
Christina Teng, Jordan Cohen, Sam Egger, Prunella L. Blinman & Janette L. Vardy. (2021) Systematic review of long-term chemotherapy-induced peripheral neuropathy (CIPN) following adjuvant oxaliplatin for colorectal cancer. Supportive Care in Cancer 30:1, pages 33-47.
Crossref
Hester.R. Trompetter, Cynthia S. Bonhof, Lonneke V. van de Poll-Franse, Gerard Vreugdenhil & Floortje Mols. (2021) Exploring the relationship among dispositional optimism, health-related quality of life, and CIPN severity among colorectal cancer patients with chronic peripheral neuropathy. Supportive Care in Cancer 30:1, pages 95-104.
Crossref
Jamie Burgess, Maryam Ferdousi, David Gosal, Cheng Boon, Kohei Matsumoto, Anne Marshall, Tony Mak, Andrew Marshall, Bernhard Frank, Rayaz A. Malik & Uazman Alam. (2021) Chemotherapy-Induced Peripheral Neuropathy: Epidemiology, Pathomechanisms and Treatment. Oncology and Therapy 9:2, pages 385-450.
Crossref
Jialin Gu, Hong Lu, Chen Chen, Zhancheng Gu, Miao Hu, Ling Liu, Jialin Yu, Guoli Wei & Jiege Huo. (2021) Diabetes mellitus as a risk factor for chemotherapy-induced peripheral neuropathy: a meta-analysis. Supportive Care in Cancer 29:12, pages 7461-7469.
Crossref
Likun Zhou, Rui Liu, Dingzhi Huang, Hongli Li, Tao Ning, Le Zhang, Shaohua Ge, Ming Bai, Xia Wang, Yuchong Yang, XinYi Wang, Xingyun Chen, Zhiying Gao, Laizhi Luo, Yuanquan Yang, Xi Wu, Ting Deng & Yi Ba. (2021) Monosialotetrahexosylganglioside in the treatment of chronic oxaliplatin-induced peripheral neurotoxicity: TJMUCH-GI-001, a randomised controlled trial. eClinicalMedicine 41, pages 101157.
Crossref
Suganija Lakkunarajah, Daniel A. Breadner, Hanbo Zhang, Ellen Yamanaka, Andrew Warner & Stephen Welch. (2021) The Influence of Adjuvant Chemotherapy Dose Intensity on Five-Year Outcomes in Resected Colon Cancer: A Single Centre Retrospective Analysis. Current Oncology 28:5, pages 4031-4041.
Crossref
Mar Sempere-Bigorra, Iván Julián-Rochina & Omar Cauli. (2021) Chemotherapy-Induced Neuropathy and Diabetes: A Scoping Review. Current Oncology 28:4, pages 3124-3138.
Crossref
Alexander V. Chen & Talin Evazyan. (2021) Development of Upper Extremity Complex Regional Pain Syndrome After Prolonged Surgery in Lithotomy Position: A Case Report. A&A Practice 15:8, pages e01507.
Crossref
Chih-Jung Wu, Kuan-Jung Huang, Yi-Chuan Tsai, Tzu-Pei Yeh, Chia-Fen Hsieh & Ya-Jung Wang. (2021) Peripheral Neuropathy: Comparison of Symptoms and Severity Between Colorectal Cancer Survivors and Patients With Diabetes. Clinical Journal of Oncology Nursing 25:4, pages 395-403.
Crossref
Roser Velasco, Montserrat Alemany, Macarena Villagrán & Andreas A. Argyriou. (2021) Predictive Biomarkers of Oxaliplatin-Induced Peripheral Neurotoxicity. Journal of Personalized Medicine 11:7, pages 669.
Crossref
Shangming Zhang. (2021) Chemotherapy-induced peripheral neuropathy and rehabilitation: A review. Seminars in Oncology 48:3, pages 193-207.
Crossref
Thierry Andre, Mayur Amonkar, Josephine M Norquist, Kai-Keen Shiu, Tae Won Kim, Benny Vittrup Jensen, Lars Henrik Jensen, Cornelis J A Punt, Denis Smith, Rocio Garcia-Carbonero, Isabel Sevilla, Christelle De La Fouchardiere, Fernando Rivera, Elena Elez, Luis A DiazJrJr, Takayuki Yoshino, Eric Van Cutsem, Ping Yang, Mohammed Farooqui & Dung T Le. (2021) Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial. The Lancet Oncology 22:5, pages 665-677.
Crossref
Marie Selvy, Nicolas Kerckhove, Bruno Pereira, Fantine Barreau, Daniel Nguyen, Jérôme Busserolles, Fabrice Giraudet, Aurélie Cabrespine, Carine Chaleteix, Martin Soubrier, Jacques-Olivier Bay, Richard Lemal & David Balayssac. (2021) Prevalence of Chemotherapy-Induced Peripheral Neuropathy in Multiple Myeloma Patients and its Impact on Quality of Life: A Single Center Cross-Sectional Study. Frontiers in Pharmacology 12.
Crossref
Diamantis I. Tsilimigras, Pnina Brodt, Pierre-Alain Clavien, Ruth J. Muschel, Michael I. D’Angelica, Itaru Endo, Rowan W. Parks, Majella Doyle, Eduardo de Santibañes & Timothy M. Pawlik. (2021) Liver metastases. Nature Reviews Disease Primers 7:1.
Crossref
Amy Davies, Caroline Lum, Rachel Raju, Evan Ansell, Kate Webber & Eva Segelov. (2021) Anti‐cancer therapy made easier: a 25‐year update. Internal Medicine Journal 51:4, pages 473-480.
Crossref
Cynthia S. Bonhof, Lonneke V. van de Poll-Franse, Dareczka K. Wasowicz, Laurens V. Beerepoot, Gerard Vreugdenhil & Floortje Mols. (2020) The course of peripheral neuropathy and its association with health-related quality of life among colorectal cancer patients. Journal of Cancer Survivorship 15:2, pages 190-200.
Crossref
Lin-Feng Wu, Meng-Meng Zheng, Wei-Ke Chen & Rong-Guo Xiao. (2021) Effect of irinotecan-assisted FOLFOX chemotherapy regimen on serum levels of tumor markers, miR-200a, and miR-190 in patients with colorectal cancer. World Chinese Journal of Digestology 29:6, pages 299-305.
Crossref
Rachel Henbrey. (2021) Stoma formation as a palliative procedure: the role of the clinical nurse specialist in maintaining quality of life. British Journal of Nursing 30:6, pages S4-S10.
Crossref
Guoli Wei, Zhancheng Gu, Jialin Gu, Jialin Yu, Xiaofei Huang, Fengxia Qin, Lingchang Li, Rong Ding & Jiege Huo. (2021) Platinum accumulation in oxaliplatin‐induced peripheral neuropathy. Journal of the Peripheral Nervous System 26:1, pages 35-42.
Crossref
Jeremy Chung Bo Chiang, David Goldstein, Terry Trinh, Kimberley Au, Susanna B. Park, Arun V. Krishnan & Maria Markoulli. (2021) A cross-sectional study of ocular surface discomfort and corneal nerve dysfunction after paclitaxel treatment for cancer. Scientific Reports 11:1.
Crossref
Xiao Luo, Susan Storey, Priyanka Gandhi, Zuoyi Zhang, Megan Metzger & Kun Huang. (2021) Analyzing the symptoms in colorectal and breast cancer patients with or without type 2 diabetes using EHR data. Health Informatics Journal 27:1, pages 146045822110007.
Crossref
Gisele Graça Leite dos Santos, Anna Lethícia Lima Oliveira, Dourivaldo Silva Santos, Renan Fernandes do Espírito Santo, Daniela Nascimento Silva, Paulo José Lima Juiz, Milena Botelho Pereira Soares & Cristiane Flora Villarreal. (2021) Mesenchymal stem cells reduce the oxaliplatin-induced sensory neuropathy through the reestablishment of redox homeostasis in the spinal cord. Life Sciences 265, pages 118755.
Crossref
Angie C. A. Chiang, Alexandre V. Seua, Pooja Singhmar, Luis D. Arroyo, Rajasekaran Mahalingam, Jian Hu, Annemieke Kavelaars & Cobi J. Heijnen. (2020) Bexarotene normalizes chemotherapy-induced myelin decompaction and reverses cognitive and sensorimotor deficits in mice. Acta Neuropathologica Communications 8:1.
Crossref
Gianluca Mauri, Viviana Gori, Erica Bonazzina, Alessio Amatu, Federica Tosi, Katia Bencardino, Lorenzo Ruggieri, Giorgio Patelli, Sabrina Arena, Alberto Bardelli, Salvatore Siena & Andrea Sartore-Bianchi. (2020) Oxaliplatin retreatment in metastatic colorectal cancer: Systematic review and future research opportunities. Cancer Treatment Reviews 91, pages 102112.
Crossref
Marie Selvy, Bruno Pereira, Nicolas Kerckhove, Coralie Gonneau, Gabrielle Feydel, Caroline Pétorin, Agnès Vimal-Baguet, Sergey Melnikov, Sharif Kullab, Mohamed Hebbar, Olivier Bouché, Florian Slimano, Vincent Bourgeois, Valérie Lebrun-Ly, Frédéric Thuillier, Thibault Mazard, David Tavan, Kheir Eddine Benmammar, Brigitte Monange, Mohamed Ramdani, Denis Péré-Vergé, Floriane Huet-Penz, Ahmed Bedjaoui, Florent Genty, Cécile Leyronnas, Jérôme Busserolles, Sophie Trevis, Vincent Pinon, Denis Pezet & David Balayssac. (2020) Long-Term Prevalence of Sensory Chemotherapy-Induced Peripheral Neuropathy for 5 Years after Adjuvant FOLFOX Chemotherapy to Treat Colorectal Cancer: A Multicenter Cross-Sectional Study. Journal of Clinical Medicine 9:8, pages 2400.
Crossref
Kristine Bennedsgaard, Lise Ventzel, Andreas C. Themistocleous, David L. Bennett, Anders B. Jensen, Anni R. Jensen, Niels T. Andersen, Troels S. Jensen, Hatice Tankisi & Nanna B. Finnerup. (2020) Long‐term symptoms of polyneuropathy in breast and colorectal cancer patients treated with and without adjuvant chemotherapy. Cancer Medicine 9:14, pages 5114-5123.
Crossref
Claire J. Han, Gee S. Yang & Karen Syrjala. (2020) Symptom Experiences in Colorectal Cancer Survivors After Cancer Treatments. Cancer Nursing 43:3, pages E132-E158.
Crossref
Grace A. Kanzawa-Lee. (2020) Chemotherapy-Induced Peripheral Neuropathy. Journal of Infusion Nursing 43:3, pages 155-166.
Crossref
Shangfeng Sun, Xiuxiu Yang, Xingping Qin & Yuekun Zhao. (2020) TCF4 promotes colorectal cancer drug resistance and stemness via regulating ZEB1/ZEB2 expression. Protoplasma 257:3, pages 921-930.
Crossref
Paola Alberti, Guido Cavaletti & David R. Cornblath. (2019) Toxic neuropathies: Chemotherapy Induced Peripheral Neurotoxicity. Current Opinion in Neurology 32:5, pages 676-683.
Crossref
. (2019) Oxaliplatin. Reactions Weekly 1752:1, pages 305-305.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.